Related Experiment Videos
PD-1: an inhibitory immunoreceptor involved in peripheral tolerance
1Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Yoshida Konoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
Trends in Immunology
|April 27, 2001
Summary
Programmed cell death protein 1 (PD-1) deficiency leads to autoimmune diseases, indicating its crucial role in maintaining peripheral tolerance. The PD-1-PD-L system on organ cells may prevent autoimmunity by providing essential negative signals.
Area of Science:
- Immunology
- Autoimmunity
- Molecular Biology
Background:
- Programmed cell death protein 1 (PD-1) deficiency is linked to various autoimmune diseases.
- The PD-1 receptor's inhibitory signaling is potentially involved in regulating peripheral tolerance.
- PD-1 ligands (PD-L1, PD-L2) are constitutively expressed on parenchymal cells in organs like the heart, lung, and kidney.
Purpose of the Study:
- To investigate the role of the PD-1-PD-L system in preventing autoimmune diseases.
- To understand how PD-1 signaling contributes to peripheral tolerance.
Main Methods:
- Analysis of PD-1 deficiency phenotypes.
- Examination of PD-1 ligand expression patterns on organ-specific cells.
- In silico or in vitro studies on PD-1 signaling pathways.
Main Results:
- PD-1 deficiency results in diverse autoimmune conditions.
- Constitutive expression of PD-L1 and PD-L2 on heart, lung, and kidney cells was observed.
- The PD-1-PD-L interaction is suggested to provide critical negative signaling.
Conclusions:
- The PD-1-PD-L axis plays a significant role in preventing autoimmune diseases.
- PD-1 signaling on parenchymal cells is a key mechanism for maintaining self-tolerance.
- Targeting the PD-1-PD-L system could offer therapeutic strategies for autoimmune disorders.